|
EQRX
|
EQRx, Inc.
|
0.29%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.27%
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.27%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
0.26%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.24%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.21%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.20%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.20%
|
US
|
NASDAQ
|
|
KZR
|
Kezar Life Sciences, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.19%
|
US
|
NASDAQ
|